China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...

WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese ...

WuXi Biologics’ move to sell the facility could strengthen the company’s cash flow and margins as it navigates global ...

The Financial Times had reported in October, citing people familiar with the matter, that WuXi and WuXi AppTec are planning ...

M-Trust is a secure cyber-physical trust platform that enables the creation of digital twins for enhanced product quality and ...

Merck & Co.'s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as ...

China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...

Bioconjugation Market Bioconjugation Market Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "Bioconjugation Market by Product ...

UPDATED: Friday, Jan. 3 at 2:45 pm ET GSK’s IL-5 inhibitor Nucala scored a nod in China to treat people with ... 1:45pm ET Shortly before the new year, Merck & Co. scored an approval for its ...

Last Friday, the Medicines and Healthcare Products Regulatory Agency approved Merck & Co Inc’s (NYSE ... concerns over its Gardasil franchise in China and uncertainty around filling the revenue ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

German stocks are modestly higher Monday morning with investors reacting to data on Germany's composite and services sector PMI ...